+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Diagnostic significance of anti-HBcIgM prevalence related to symptoms in Canadian patients acutely or chronically infected with hepatitis B virus



Diagnostic significance of anti-HBcIgM prevalence related to symptoms in Canadian patients acutely or chronically infected with hepatitis B virus



Journal of Medical Virology 20(3): 269-277



A total of 362 sera from 295 Canadian patients were examined for HBsAg, anti-HBs, anti-HBc, anti-HBcIgM, HBeAg, and anti-HBe using commercial immunoassays. Serial samples from 70 acutely infected patients demonstrated that anti-HBcIgM may detect 10% more positives than HBsAg within 4 months after the onset of clinical symptoms, and all except two were negative for anti-HBcIgM after the fourth month. None of 66 asymptomatic (HBeAg rate 18.2%) and two of 14 (14.3%) symptomatic (HBeAg rate 64.3%) carriers of HBsAg were positive for anti-HBcIgM (P = 0.029). Elevated marker responses were measured in two symptomatic carriers for a 20-month period. Anti-HBcIgM was not detected in either 100 asymptomatic patients positive for total anti-HBc, negative for HBsAg and negative for or possessing low levels of anti-HBs, 25 patients with liver disorders not caused by HBV, or 20 healthy milk donors. In diagnostic laboratory practice this anti-HBcIgM test may be useful in the following situations: to supplement HBsAg testing, providing a theoretical 10% increase in positives within 4 months following onset of acute viral hepatitis; to replace testing for anti-HBc and anti-HBs in symptomatic HBsAg-negative patients; to confirm whether a patient is experiencing acute or chronic HBV infection or symptoms superimposed upon asymptomatic HBsAg carriage by another cause, such as nonA-nonB viral hepatitis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039812345

Download citation: RISBibTeXText

PMID: 3537207

DOI: 10.1002/jmv.1890200309


Related references

Diagnostic significance of anti hepatitis b core antigen immunoglobulin m prevalence related to symptoms in canadian patients acutely or chronically infected with hepatitis b virus. Journal of Medical Virology 20(3): 269-278, 1986

Diagnostic significance of antibodies to hepatitis B virus polymerase in acutely and chronically HBV-infected individuals. Journal Of Medical Virology. 40(4): 285-290, 1993

Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients. Medical Microbiology and Immunology 198(1): 13-18, 2009

Clinical and histologic significance of positive anti-smooth muscle antibody in patients chronically infected with hepatitis C virus. Gastroenterology 116(4 Part 2): A1260, 1999

Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients. Aids 21(5): 652-653, 2007

Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients. HIV Medicine 15(9): 571-576, 2014

Genetic changes in hepatitis delta virus from acutely and chronically infected woodchucks. Journal of Virology 80(13): 6469-6477, 2006

Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. Journal of Gastroenterology 38(4): 355-360, 2003

PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies. Journal of Medical Virology 82(1): 23-31, 2010

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. Journal of Clinical Investigation 100(9): 2376-2385, 1997

HBeAg/anti-HBe circulating immune complexes in patients chronically infected with hepatitis B virus. La Ricerca in Clinica e in Laboratorio 19(1): 81-91, 1989

Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia. Journal of Medical Virology 82(7): 1160-1167, 2010

Prevalence of hepatitis C virus isolate genotypes from chronically infected Lebanese patients: a hospital-based study. Le Journal Medical Libanais. Lebanese Medical Journal 51(3): 121-126, 2005